The research group of Professor Suwei Dong has made progress in the chemical synthesis and glycosyl function study of glycoproteins.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 2, p. 187
- Publication type:
- Article
Works matching IS 10031057 AND DT 2021 AND VI 30 AND IP 2
Results: 12
1
2
The group of Professor Pengfei Tu/Kewu Zeng has made progress in the study of anti-cerebral ischemia target of Cistanche deserticola.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 2, p. 185
- Publication type:
- Article
3
The group of Professor Tao Liu used a supramolecular recognition strategy to achieve reversible regulation of protein.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 2, p. 183
- Publication type:
- Article
4
The group of Professor Tao Liu used biosynthesis strategies to achieve diverse modifications of protein drugs.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 2, p. 181
- Publication type:
- Article
5
The research group of Professor Wanliang Lv has made progress in the study of targeted functional liposomes against drug-resistant breast cancer.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 2, p. 179
- Publication type:
- Article
6
A comparative study on different multiple cropping patterns of Bupleurum chinense.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 2, p. 169, doi. 10.5246/jcps.2021.02.014
- By:
- Publication type:
- Article
7
Identification of major compounds of total flavonoids from Smilax china and evaluation of anti-inflammatory effect on phenol mucilage-induced pelvic inflammation in rats.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 2, p. 157, doi. 10.5246/jcps.2021.02.013
- By:
- Publication type:
- Article
8
Preclinical efficacy of a novel cyclin-dependent kinase 9 inhibitor, QHRD107 against acute myeloid leukemia.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 2, p. 146, doi. 10.5246/jcps.2021.02.012
- By:
- Publication type:
- Article
9
Analysis of the effect of HCV resistance-associated substitutions on the short-term efficacy of DAA after single administration in three phase Ib clinical trials.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 2, p. 133, doi. 10.5246/jcps.2021.02.011
- By:
- Publication type:
- Article
10
A PK/PD model of saxagliptin: to simulate its pharmacokinetics and pharmacodynamics in healthy adults and patients with impaired hepatic function.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 2, p. 119, doi. 10.5246/jcps.2021.02.010
- By:
- Publication type:
- Article
11
Proteomic analysis on cellular response induced by nanoparticles reveals the nano-trafficking pathway through epithelium.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 2, p. 107, doi. 10.5246/jcps.2021.02.009
- By:
- Publication type:
- Article
12
Significance of neutralizing antibodies in COVID-19 therapy: progress and prospect.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2021, v. 30, n. 2, p. 87, doi. 10.5246/jcps.2021.02.008
- By:
- Publication type:
- Article